A detailed history of Fernwood Investment Management, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 513,136 shares of PLRX stock, worth $6.82 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
513,136
Previous 496,286 3.4%
Holding current value
$6.82 Million
Previous $5.34 Million 7.82%
% of portfolio
1.9%
Previous 1.67%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$10.52 - $14.35 $177,262 - $241,797
16,850 Added 3.4%
513,136 $5.75 Million
Q2 2024

Jul 31, 2024

BUY
$10.58 - $15.61 $506,792 - $747,734
47,901 Added 10.68%
496,286 $5.34 Million
Q1 2024

May 13, 2024

BUY
$14.14 - $19.59 $356,441 - $493,824
25,208 Added 5.96%
448,385 $6.68 Million
Q4 2023

Feb 05, 2024

BUY
$12.85 - $19.15 $558,653 - $832,546
43,475 Added 11.45%
423,177 $7.66 Million
Q3 2023

Nov 08, 2023

SELL
$14.58 - $20.15 $14,944 - $20,653
-1,025 Reduced 0.27%
379,702 $6.58 Million
Q2 2023

Aug 09, 2023

BUY
$18.12 - $30.56 $1.22 Million - $2.06 Million
67,479 Added 21.54%
380,727 $6.9 Million
Q1 2023

May 01, 2023

BUY
$18.73 - $36.26 $162,482 - $314,555
8,675 Added 2.85%
313,248 $8.33 Million
Q4 2022

Feb 07, 2023

BUY
$17.0 - $25.43 $1.39 Million - $2.08 Million
81,816 Added 36.73%
304,573 $5.89 Million
Q3 2022

Nov 09, 2022

BUY
$7.67 - $24.23 $80,895 - $255,553
10,547 Added 4.97%
222,757 $4.65 Million
Q2 2022

Aug 11, 2022

BUY
$4.11 - $8.75 $107,271 - $228,375
26,100 Added 14.02%
212,210 $1.7 Million
Q1 2022

May 03, 2022

BUY
$7.01 - $14.1 $83,068 - $167,085
11,850 Added 6.8%
186,110 $1.76 Million
Q4 2021

Feb 09, 2022

BUY
$12.27 - $18.26 $95,865 - $142,665
7,813 Added 4.69%
174,260 $2.35 Million
Q3 2021

Oct 28, 2021

BUY
$16.48 - $28.98 $252,737 - $444,437
15,336 Added 10.15%
166,447 $2.81 Million
Q2 2021

Aug 05, 2021

BUY
$28.05 - $37.69 $4.24 Million - $5.7 Million
151,111 New
151,111 $4.41 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $647M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Fernwood Investment Management, LLC Portfolio

Follow Fernwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.